Genomic Dynamics in Colorectal Cancer Metastasis

Colorectal cancer metastasis is governed by a complex interplay of genetic alterations, clonal diversification and microenvironmental selection. Primary tumours and their distant lesions often share a core set of driver mutations in genes such as APC, KRAS and TP53, while additional site-specific changes emerge during dissemination. High-depth sequencing and spatial profiling have revealed that copy-number variations and non-coding mutations can differ markedly between primary and metastatic sites, reflecting divergent evolutionary trajectories. Clonal analyses show that only a minority of subclones in the primary lesion succeed in colonising distant organs, with genetic programmes for adhesion, extracellular matrix remodelling and organotropism shaping colonisation patterns. Real-time monitoring via circulating tumour DNA and single-cell approaches has further illuminated temporal shifts in genomic heterogeneity, highlighting Darwinian selection in early lesions and neutral drift in advanced disease. Better understanding of these dynamics is critical for precision medicine, offering routes to site-specific biomarkers and tailored therapeutic strategies.

Research from Nature Portfolio

Recent studies have employed whole-genome sequencing to chart the mutational landscape of matched primary and metastatic colorectal tumours, demonstrating that roughly two-thirds of somatic mutations arise in a common ancestral clone, while the remainder distribute into tumour- and metastasis-specific branches. Analysis of non-coding elements and metastasis-enriched pathways such as PI3K-Akt signalling has uncovered actionable lesions restricted to secondary sites. Complementary work using targeted high-depth sequencing across multiple spatial regions of individual tumours has revealed that DNA copy-number alterations exhibit pronounced heterogeneity along morphological axes, whereas key coding mutations remain uniformly distributed. In parallel, high-resolution phylogenetic mapping of lymphatic spread has defined diverse modes of nodal dissemination, including direct seeding from primary tumours and re-seeding between nodes, underscoring the complexity of metastatic routes and suggesting that skip-metastasis contributes to clinical relapse patterns.

Genomic Dynamics in Colorectal Cancer Metastasis publication trend

The graph below shows the total number of articles in genomic dynamics in colorectal cancer metastasis across all publications each year (not limited to Nature Index journals).

Technical terms

Clonal evolution: Process by which tumour cell populations acquire and select genetic changes over time.

Intratumour heterogeneity: Genetic and phenotypic diversity among cells within a single tumour.

Copy-number variation (CNV): Gains or losses of large DNA segments that alter gene dosage.

Mutational signature: Characteristic pattern of DNA changes reflecting specific mutational processes.

Circulating tumour DNA (ctDNA): Fragments of tumour-derived DNA released into the bloodstream.

Phylogenetic mapping: Reconstruction of evolutionary relationships among tumour subclones.

References

1. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases. Cancer Cell International (2023).
2. Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers (2023).
3. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biology (2014).
4. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nature Communications (2018).
5. DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer. Nature Communications (2017).
6. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer. Nature Communications (2018).
7. Mapping the spreading routes of lymphatic metastases in human colorectal cancer. Nature Communications (2020).
8. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors. Genome Medicine (2022).